These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37522337)

  • 1. Emergency Regulatory Procedures, Pharmaceutical Regulatory Politics, and the Political Economy of Vaccine Regulation in the COVID-19 Pandemic.
    Nachlis H; Thomson K
    J Health Polit Policy Law; 2024 Feb; 49(1):73-98. PubMed ID: 37522337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of political disagreements and corruption on state health leader turnover during the COVID-19 pandemic in Brazil.
    Barberia LG; Masiero G; Alves de Lima I; Santana L; Moraes de Sousa TC
    Leadersh Health Serv (Bradf Engl); 2024 Jun; ahead-of-print(ahead-of-print):. PubMed ID: 38884379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Political variations in pandemic lifestyles and COVID-19 vaccination by age cohort in the United States.
    Dowd-Arrow B; Burdette AM; Smith A
    Prev Med; 2023 Jul; 172():107525. PubMed ID: 37164162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EU's Ordering of COVID-19 Vaccine Doses: Political Decision-Making under Uncertainty.
    Gleißner W; Follert F; Daumann F; Leibbrand F
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global inequities in access to COVID-19 health products and technologies: A political economy analysis.
    Gleeson D; Townsend B; Tenni BF; Phillips T
    Health Place; 2023 Sep; 83():103051. PubMed ID: 37379732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical messianism and the politics of COVID-19 in the United States.
    Lasco G; Yu VG; Bharti N
    Glob Public Health; 2024 Jan; 19(1):2350656. PubMed ID: 38718289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Politics overwhelms science in the Covid-19 pandemic: Evidence from the whole coverage of the Italian quality newspapers.
    Crabu S; Giardullo P; Sciandra A; Neresini F
    PLoS One; 2021; 16(5):e0252034. PubMed ID: 34015013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On symbols and scripts: The politics of the American COVID-19 response.
    Kenworthy N; Koon AD; Mendenhall E
    Glob Public Health; 2021; 16(8-9):1424-1438. PubMed ID: 33736578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccine decisions: considering the choices and opportunities.
    Hotez PJ; Nuzhath T; Callaghan T; Colwell B
    Microbes Infect; 2021; 23(4-5):104811. PubMed ID: 33744495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of Remote Inspections During the COVID-19 Health Emergency and in the Postpandemic Setting.
    Mofid S; Bolislis WR; Brading C; Hamilton N; Hardit C; Nagaoka M; Parain J; Zanta M; Kühler TC
    Clin Ther; 2021 Dec; 43(12):2046-2063. PubMed ID: 34740466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Words matter: political and gender analysis of speeches made by heads of government during the COVID-19 pandemic.
    Dada S; Ashworth HC; Bewa MJ; Dhatt R
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33514593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the influence of institutions, politics, organizations, and governance on the COVID-19 response in British Columbia, Canada: a jurisdictional case study protocol.
    Brubacher LJ; Hasan MZ; Sriram V; Keidar S; Wu A; Cheng M; Lovato CY; ; Berman P
    Health Res Policy Syst; 2022 Jun; 20(1):74. PubMed ID: 35729534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the evolution of the pharmaceutical regulatory environment.
    Shafiei N; Ford JL; Morecroft CW; Lisboa PJ; Taylor MJ
    PDA J Pharm Sci Technol; 2013; 67(4):297-306. PubMed ID: 23872441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Union and Public Health Emergencies: Expert Opinions on the Management of the First Wave of the COVID-19 Pandemic and Suggestions for Future Emergencies.
    Gontariuk M; Krafft T; Rehbock C; Townend D; Van der Auwermeulen L; Pilot E
    Front Public Health; 2021; 9():698995. PubMed ID: 34490183
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives in the study of the political economy of COVID-19 vaccine regulation.
    da Fonseca EM; Jarman H; King EJ; Greer SL
    Regul Gov; 2021 May; ():. PubMed ID: 34226834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.
    Moulia DL; Wallace M; Roper LE; Godfrey M; Rosenblum HG; Link-Gelles R; Britton A; Daley MF; Meyer S; Fleming-Dutra KE; Oliver SE; Twentyman E
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(24):657-662. PubMed ID: 37319020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Bollyky TJ; Castro E; Aravkin AY; Bhangdia K; Dalos J; Hulland EN; Kiernan S; Lastuka A; McHugh TA; Ostroff SM; Zheng P; Chaudhry HT; Ruggiero E; Turilli I; Adolph C; Amlag JO; Bang-Jensen B; Barber RM; Carter A; Chang C; Cogen RM; Collins JK; Dai X; Dangel WJ; Dapper C; Deen A; Eastus A; Erickson M; Fedosseeva T; Flaxman AD; Fullman N; Giles JR; Guo G; Hay SI; He J; Helak M; Huntley BM; Iannucci VC; Kinzel KE; LeGrand KE; Magistro B; Mokdad AH; Nassereldine H; Ozten Y; Pasovic M; Pigott DM; Reiner RC; Reinke G; Schumacher AE; Serieux E; Spurlock EE; Troeger CE; Vo AT; Vos T; Walcott R; Yazdani S; Murray CJL; Dieleman JL
    Lancet; 2023 Apr; 401(10385):1341-1360. PubMed ID: 36966780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social policy as an integral component of pandemic response: Learning from COVID-19 in Brazil, Germany, India and the United States.
    Greer SL; Jarman H; Falkenbach M; Massard da Fonseca E; Raj M; King EJ
    Glob Public Health; 2021; 16(8-9):1209-1222. PubMed ID: 33876715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making US poison centers a part of the solution to the COVID-19 pandemic.
    Spyker DA; Bronstein AC; Weber JA
    Clin Toxicol (Phila); 2022 Jan; 60(1):102-114. PubMed ID: 34448649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.